Najat Khan, PhD

Najat Khan, PhD, is a prominent figure in the pharmaceutical and healthcare industry who recently joined Recursion Pharmaceuticals as Chief R&D Officer and Chief Commercial Officer, while also becoming a member of the company's Board of Directors.134

Professional Background

Prior to joining Recursion, Dr. Khan held significant roles at Johnson & Johnson (J&J), including:

• Chief Data Science Officer and Global Head of Strategy and Portfolio Organization for Innovative Medicine R&D34
• Co-chair of the Johnson & Johnson Data Science Council6

At J&J, she played a crucial role in building an industry-leading pipeline that delivered multiple transformational medicines.3 Dr. Khan has been a pioneer in leveraging data science and AI at scale in the pharmaceutical industry.3

Expertise and Focus

Dr. Khan's expertise spans several areas:

• Biological, chemical, and medical sciences
• Computational and data science
• General business leadership

Her mission focuses on harnessing the power of science, data, and AI to revolutionize the discovery, development, and delivery of transformative medicines for patients.34

Education and Achievements

• PhD in Organic Chemistry from the University of Pennsylvania13
• BA in Computational Chemistry with a minor in Economics from Colgate University12
• Published in high-impact journals such as Nature and Proceedings of the National Academy of Sciences2
• Named on Endpoints News' list of top 20 leaders under 40 in biopharma and biotech in 20221

Additional Roles and Initiatives

• Board member for Alliance for Artificial Intelligence in Healthcare35
• Steering Committee member of the White House's Moonshot CancerX program35
• Founder and co-chair of the Data Science in Industry Roundtable (DISRUPT)35

Dr. Khan's unique blend of scientific expertise, data science knowledge, and business acumen positions her as a leader in the evolving landscape of AI-enabled drug discovery and development.